Annette Skovby
Research Subjects
Annette Skovby has a total of 28 co-authors. Here are the top co-authors by number of shared publications:
Agnieszka Barbara Olsén
Department of Clinical Microbiology, Herlev and Gentofte Hospital – University Hospital, Herlev, Denmark
1 shared publicationAstrid Rasmussen
Bacteria, Parasites and Fungi, Statens Serum Institut, Copenhagen, Denmark
1 shared publication- Charlotte Munkstrup
Infectious Disease Epidemiology and Prevention, Statens Serum Institut, Copenhagen, Denmark
1 shared publication Christian Salgaard Jensen
Department of Clinical Microbiology, Rigshospitalet, Copenhagen, Denmark
1 shared publication- Claus Østergaard
Department of Clinical Microbiology, Lillebaelt Hospital, Vejle, Denmark
1 shared publication - David Fuglsang-Damgaard
Aalborg University Hospital
1 shared publication
Latest Publications
- Top Cited PapersOpen Access
- 29 June 2023
- Published by European Centre for Disease Control and Prevention (ECDC) in Eurosurveillance
- Vol. 28 (26) , 2300291
Increase in invasive group A streptococcal infections and emergence of novel, rapidly expanding sub-lineage of the virulent Streptococcus pyogenes M1 clone, Denmark, 2023
A highly virulent sub-lineage of the Streptococcus pyogenes M1 clone has been rapidly expanding throughout Denmark since late 2022 and now accounts for 30% of the new invasive group A streptococcal infections. We aimed to investigate whether a shift in variant composition can account for the high incidence rates observed over winter 2022/23, or if these are better explained by the impact of COVID-19-related restrictions on population immunity and carriage of group A Streptococcus.
- 29 June 2023
- Published by European Centre for Disease Control and Prevention (ECDC) in Eurosurveillance
- Vol. 28 (26) , 2300291
Top Cited PapersOpen AccessIncrease in invasive group A streptococcal infections and emergence of novel, rapidly expanding sub-lineage of the virulent Streptococcus pyogenes M1 clone, Denmark, 2023
A highly virulent sub-lineage of the Streptococcus pyogenes M1 clone has been rapidly expanding throughout Denmark since late 2022 and now accounts for 30% of the new invasive group A streptococcal infections. We aimed to investigate whether a shift in variant composition can account for the high incidence rates observed over winter 2022/23, or if these are better explained by the impact of COVID-19-related restrictions on population immunity and carriage of group A Streptococcus.